Results

Glenmark Pharmaceuticals Ltd. - Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2018

| Updated on February 14, 2019 Published on February 14, 2019

Sub: Outcome of the Board Meeting - February 14, 2019

Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR, 2015)

Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2018.

The said meeting of the Board commenced at 2.00 p.m. and concluded at 4.44 p.m.

The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.

These are also being made available on the website of the Company at www.glenmarkpharma.com.

Pdf Link: Glenmark Pharmaceuticals Ltd. - Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2018

Source : BSE - www.bseindia.com

Published on February 14, 2019
This article is closed for comments.
Please Email the Editor